12.03.2024 17:00:56
|
Convatec Group PLC: Director/ PDMR Shareholding
Convatec Group PLC (CTEC)
12 March 2024 Convatec Group Plc Director/ PDMR Shareholding The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility (“PDMR”) in respect of ordinary shares of 10 pence each in the Company (“Shares”).
On the 11 March 2024, awards were granted to Karim Bitar, Chief Executive Officer and Jonny Mason, Chief Financial Officer under the LTIP in the form of Performance Share Units (“PSUs”). These awards are due to vest on the third anniversary of grant, conditional on the following performance conditions: adjusted PBT growth, organic revenue growth, and TSR over the three financial years to 31 December 2026; and subject to a two-year post vesting holding period. Further details of the LTIP and performance conditions will be available in the Company’s 2023 Annual Report.
Karim Bitar: 1,025,891
Jonny Mason: 464,221
On the same date, awards were also granted to Karim Bitar and Jonny Mason, under the DBP in the form of restricted stock units (“RSUs”), which are due to vest on the third anniversary of grant and are not subject to performance conditions: Karim Bitar: 226,266 Jonny Mason: 122,863 The three-day average share price, closing on 8 March 2024 of £2.76 was used in determining the awards.
Also on 11 March 2024, share awards granted to Karim Bitar in 2021 under the LTIP vested:
On the same day, awards granted to Karim Bitar in 2021 under the DBP, vested:
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Enquiries Ria Banerjee, Group Deputy Company Secretary Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2023 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit www.convatecgroup.com Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
ISIN: | GB00BD3VFW73 |
Category Code: | DSH |
TIDM: | CTEC |
LEI Code: | 213800LS272L4FIDOH92 |
Sequence No.: | 309248 |
EQS News ID: | 1857091 |
End of Announcement | EQS News Service |
|
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ConvaTec PLCmehr Nachrichten
23.12.24 |
FTSE 100-Wert ConvaTec-Aktie: So viel hätten Anleger mit einem Investment in ConvaTec von vor einem Jahr verloren (finanzen.at) | |
16.12.24 |
FTSE 100 aktuell: FTSE 100 beendet den Handel im Minus (finanzen.at) | |
16.12.24 |
Montagshandel in London: FTSE 100 zeigt sich nachmittags leichter (finanzen.at) | |
09.12.24 |
FTSE 100-Papier ConvaTec-Aktie: So viel hätten Anleger an einem ConvaTec-Investment von vor 5 Jahren verdient (finanzen.at) | |
06.12.24 |
Aufschläge in London: FTSE 100 notiert mittags im Plus (finanzen.at) | |
06.12.24 |
FTSE 100-Handel aktuell: FTSE 100 legt zum Start den Rückwärtsgang ein (finanzen.at) | |
03.12.24 |
Pluszeichen in London: FTSE 100 legt am Mittag zu (finanzen.at) | |
03.12.24 |
Dienstagshandel in London: FTSE 100 zum Start des Dienstagshandels mit Zuschlägen (finanzen.at) |